Page 32 - TD-3-4
P. 32

Tumor Discovery                                                        Expert consensus of NUT carcinoma



               of children and young adults with NUT rearrangement.   18.  Chau NG, Ma C, Danga K, et al. An anatomical site and
               J Clin Oncol. 2004;22(20):4135-4139.               genetic-based  prognostic  model  for patients with  Nuclear
               doi: 10.1200/JCO.2004.02.107                       Protein in Testis (NUT)  midline carcinoma: Analysis of
                                                                  124 patients. JNCI Cancer Spectr. 2020;4(2):pkz94.
            7.   Shehata  BM,  Steelman  CK,  Abramowsky  CR,  et al.
               NUT midline carcinoma in a newborn with multiorgan      doi: 10.1093/jncics/pkz094
               disseminated  tumor  and  a  2-year-old  with  a  pancreatic/  19.  Scherman N, Wassermann J, Tlemsani C,  et al. Possible
               hepatic primary. Pediatr Dev Pathol. 2010;13(6):481-485.  primary thyroid nuclear protein in testis carcinomas with
               doi: 10.2350/09-10-0727-CR.1                       NSD3:NUTM1 translocation revealed by RNA sequencing:
                                                                  A report of two cases. Thyroid. 2022;32(10):1271-1276.
            8.   Dickson BC, Sung YS, Rosenblum MK, et al. NUTM1 gene
               fusions characterize a subset of undifferentiated soft tissue      doi: 10.1089/thy.2022.0136
               and visceral tumors. Am J Surg Pathol. 2018;42(5):636-645.  20.  Napolitano M, Venturelli M, Molinaro E, Toss A. NUT
               doi: 10.1097/PAS.0000000000001021                  midline carcinoma of the head and neck: Current
                                                                  perspectives. Onco Targets Ther. 2019;12:3235-3244.
            9.   Mertens F, Wiebe T, Adlercreutz C, Mandahl N, French CA.
               Successful treatment of a child with t(15;19)-positive tumor.      doi: 10.2147/OTT.S173056
               Pediatr Blood Cancer. 2007;49(7):1015-1017.     21.  Tontsch-Grunt U, Traexler PE, Baum A, et al. Therapeutic
               doi: 10.1002/pbc.20755                             impact of BET inhibitor BI 894999 treatment: Backtranslation
                                                                  from the clinic. Br J Cancer. 2022;127(3):577-586.
            10.  Yuan J, Xu Z, Guo Y. Diagnosis, treatment and prognosis of
               primary pulmonary NUT carcinoma: A  literature review.      doi: 10.1038/s41416-022-01815-5
               Curr Oncol. 2022;29(10):6807-6815.
                                                               22.  Yu D, Liang Y, Kim C, et al. Structural mechanism of BRD4-
               doi: 10.3390/curroncol29100536                     NUT and p300 bipartite interaction in propagating aberrant
            11.  Ribeiro da Costa AEA, Santos IL, Pereira Soares MJA, Reis   gene transcription in chromatin in NUT carcinoma.  Nat
               de Paula ID, da Silva Júnior RG, Coelho de Sá CE. A case of   Commun. 2023;14(1):378.
               metastatic NUT carcinoma of the nasal cavity. Oral Oncol.      doi: 10.1038/s41467-023-36063-5
               2023;142:106432.
                                                               23.  World Health Organization. WHO Handbook for Guideline
               doi: 10.1016/j.oraloncology.2023.106432            Development [EB/OL]. 2  ed. Geneva, Switzerland: World
                                                                                    nd
            12.  Jimenez C, Stanton E, Kondra K, et al. NUT carcinoma of   Health Organization. Available from: https://www.who.
               the mandible in a child: Case report and systematic review.   int/groups/guidelines-reviewcommittee  [Last  accessed  on
               Int J Oral Maxillofac Surg. 2023;52(3):304-312.    2024 Apr 03].
               doi: 10.1016/j.ijom.2022.07.002                 24.  Brouwers MC, Kho ME, Browman GP,  et al. AGREE II:
                                                                  Advancing guideline development, reporting and evaluation
            13.  Ribeiro JA, Sousa J, Jesus F,  et al. NUT carcinoma  -  An   in health care. CMAJ. 2010;182(18):E839-E842.
               aggressive thoracic tumor. Am J Med Sci. 2023;366(1):64-70.
                                                                  doi: 10.1503/cmaj.090449
               doi: 10.1016/j.amjms.2023.03.028
                                                               25.  Chen Y, Yang K, Marusic A,  et al. A  reporting tool for
            14.  Saiki A, Sakamoto K, Bee Y, Izumo T. Nuclear protein of
               the testis midline carcinoma of the thorax. Jpn J Clin Oncol.   practice  guidelines  in  health  care:  The  RIGHT  statement.
               2022;52(6):531-538.                                Ann Intern Med. 2017;166(2):128-132.
               doi: 10.1093/jjco/hyac033                          doi: 10.7326/M16-1565
                                                               26.  World Health Organization.  International Practice
            15.  Lemelle L, Pierron G, Freneaux P,  et al. NUT carcinoma
               in children and adults: A  multicenter retrospective study.   Guideline Registry Platform [EB/OL]. Geneva, Switzerland:
               Pediatr Blood Cancer. 2017;64(12): e26693.         World  Health  Organization.  Available  from:  https://
                                                                  www.guidelines-registry.cn/guid/2939 [Last accessed on
               doi: 10.1002/pbc.26693                             2024 Apr 01].
            16.  Yang SM, Zhang B. The research advances of neoplasm with   27.  Wang X, Chen Y, Yao L,  et al. Reporting of declarations
               NUTM1 gene rearrangement. Zhonghua Bing Li Xue Za Zhi.   and conflicts of interest in WHO guidelines can be further
               2022;51(3):271-275.                                improved. J Clin Epidemiol. 2018;98:1-8.
               doi: 10.3760/cma.j.cn112151-20211123-00853         doi: 10.1016/j.jclinepi.2017.12.021
            17.  French CA. Pathogenesis of NUT midline carcinoma. Annu   28.  Lemelle L, Moya-Plana A, Dumont B, et al. NUT carcinoma
               Rev Pathol. 2012;7:247-265.                        in children, adolescents and young adults.  Bull Cancer.
               doi: 10.1146/annurev-pathol-011811-132438          2022;109(4):491-504.


            Volume 3 Issue 4 (2024)                         24                                doi: 10.36922/td.4904
   27   28   29   30   31   32   33   34   35   36   37